Development and validation of a nomogram involving immunohistochemical markers for prediction of recurrence in early low-risk endometrial cancer.

The International journal of biological markers(2022)

引用 0|浏览0
暂无评分
摘要
This nomogram, with a combination of classical parameters and immunohistochemical markers, can effectively predict recurrence in early low-risk endometrial cancer patients.
更多
查看译文
关键词
Nomogram model,classical parameters,early low-risk endometrial cancer,immunohistochemical markers,recurrence
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要